Roswell Park Cancer Institute: all 418 studies

Page 4 of 5. Open to participants first (65), then studies with results posted, then the rest; newest registration first within each.

• Photodynamic Therapy in Treating Patients With Lung CancerCompletedNCT01668823Phase 1
• Bathing Bundle Regimen in Reducing Gynecological Surgical Site Infection in Patients Undergoing SurgeryCompletedNCT01597804Not applicable
• Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid TumorsTerminatedNCT01573780Phase 1
• Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantWithdrawnNCT01558778Not applicable
• Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid LeukemiaCompletedNCT01555268Phase 1
• Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid LeukemiaTerminatedNCT01550185Phase 1
• PI3K Inhibitor BKM120 and Docetaxel in Treating Patients With Advanced Solid Tumor That is Locally Advanced, Cannot Be Removed By Surgery, or MetastaticCompletedNCT01540253Phase 1
• Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerCompletedNCT01536054Phase 1
• Autofluorescence Detection of Oral Malignancies and Database and Biospecimen Collection to Identify Biomarkers of Head and Neck Tumor ProgressionCompletedNCT01531881
• Entolimod in Treating Patients With Locally Advanced or Metastatic Solid Tumors That Cannot Be Removed By SurgeryCompletedNCT01527136Phase 1
• Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsCompletedNCT01522820Phase 1
• Cholecalciferol in Treating Patients With Acute Myeloid Leukemia Undergoing Intensive Induction ChemotherapyTerminatedNCT01521936Phase 2
• Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary CancersCompletedNCT01497392Phase 1
• Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin CancerCompletedNCT01292668Phase 1
• Edible Hepatitis B Vaccine Therapy in Healthy Participants Who Have Undergone Previous VaccinationWithdrawnNCT01292421Not applicable
• Azadirachta Indica in Treating Patients With Chronic Lymphocytic LeukemiaWithdrawnNCT01251250Phase 1
• Vaccine Therapy and Sargramostim in Treating Patients With Malignant GliomaCompletedNCT01250470Phase 1
• Lenalidomide and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT01246622Phase 1
• Study To Determine The Maximum Range of Light Doses At Two HPPH Doses With Acceptable Normal Tissue Toxicity For PDT Treatment Of High Grade Dysplasia,CIS or Early Adenocarcinoma In Barrett's EsophagusCompletedNCT01238042Phase 1
• Effect of a Low Glycemic Index Diet on Breast DensityTerminatedNCT01237938Not applicable
• Study of Photodynamic Therapy (PDT) Using HPPH in Barrett's EsophagusCompletedNCT01236443Phase 1
• Exercise Intervention in Breast Cancer Patients With Treatment-Induced ArthralgiaCompletedNCT01236417Not applicable
• Brody Belt - Alternative Method of Securing a Patient's Urinary Drainage BagTerminatedNCT01228864Not applicable
• Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate CancerTerminatedNCT01174199Phase 1
• A Trial of Photodynamic Therapy With HPPH for Treatment of Dysplasia, Carcinoma in Situ and T1 Carcinoma of the Oral Cavity and/or OropharynxCompletedNCT01140178Phase 1
• Calcitriol, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by SurgeryTerminatedNCT01093092Phase 1
• Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by SurgeryCompletedNCT01061411Phase 1
• Study for the Liquid Chromatography-mass Spectrometry (LC-MS/MS) Assessment of Oxidative DNA Damage in Relation to Antioxidant UsageCompletedNCT01038024Not applicable
• Study for Determination of Feasibility and Toxicity of Pre-Treatment With HPPH (2-1[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a) Photodynamic Therapy Prior to Chemoradiation in Non-Operable Patients With Obstructive Esophageal CancerWithdrawnNCT01035437Not applicable
• Study of LBH589, A Deacetylase Inhibitor in Patients With Recurrent or Refractory Hodgkin or Non-Hodgkin's LymphomaTerminatedNCT01032148Phase 1
• Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung MetastasisCompletedNCT01014598Phase 1
• Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With MyelofibrosisTerminatedNCT01014546Phase 1
• Guided Biopsy for Mapping Prostate CancerTerminatedNCT01007214Not applicable
• Safety and Tolerability of Oral Clofarabine in Intermediate to High Risk Myelodysplastic PatientsTerminatedNCT01003678Phase 1
• Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine HydrochlorideCompletedNCT00981162Phase 1
• Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active SurveillanceWithdrawnNCT00796874Not applicable
• Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast CancerTerminatedNCT00794989Not applicable
• Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate CancerWithdrawnNCT00736164Phase 2
• Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by SurgeryCompletedNCT00732563Not applicable
• Photodynamic Therapy Using HPPH in Treating Patients With Dysplasia, Cancer in Situ, or Invasive Cancer of the LarynxCompletedNCT00675233Phase 1
• Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity CancerTerminatedNCT00670397Phase 1
• KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to TreatmentCompletedNCT00646139Phase 1
• Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung CancerWithdrawnNCT00560495Phase 1
• Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation TherapyWithdrawnNCT00559481Not applicable
• DNA Changes That Affect Vitamin D Metabolism in Patients With Colorectal Cancer Receiving Vitamin D SupplementsCompletedNCT00550563Not applicable
• Fentanyl With or Without Bupivacaine in Reducing Pain in Patients Undergoing Video-Assisted Chest SurgeryCompletedNCT00538499Not applicable
• Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal CancerCompletedNCT00537121Phase 1
• Photodynamic Therapy Using HPPH in Treating Patients With Stage 0 Non-Small Cell Lung CancerCompletedNCT00526461Phase 1
• Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal CancerTerminatedNCT00524186Phase 1
• Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By SurgeryWithdrawnNCT00524069Not applicable
• Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck CancerCompletedNCT00470496Phase 1
• Cholecalciferol and Calcium Carbonate in Treating Patients With Colon Cancer That Has Been Removed by SurgeryTerminatedNCT00470353Not applicable
• Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation TherapyCompletedNCT00403000Phase 2
• Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal CancerCompletedNCT00281736Phase 2
• Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell DisordersTerminatedNCT00258258Phase 1
• Fulvestrant in Treating Patients With Advanced Prostate CancerCompletedNCT00244998Phase 2
• Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00238225Phase 1
• Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate CancerCompletedNCT00217516Phase 1
• Paricalcitol and Gemcitabine in Treating Patients With Advanced CancerCompletedNCT00217477Phase 1
• Irinotecan and Gemcitabine in Treating Patients With Recurrent or Progressive Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00182806Phase 2
• Irinotecan and Selenium in Treating Patients With Advanced Solid TumorsCompletedNCT00112892Phase 1
• Folate-Depleted Diet Compared With Folate-Supplemented Diet in Preventing Colorectal Cancer in Patients at High Risk for Colorectal CancerCompletedNCT00096330Phase 1
• Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal CancerTerminatedNCT00093652Phase 1/2
• Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid LeukemiaCompletedNCT00093483Phase 1
• Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal CancerTerminatedNCT00087334Phase 1/2
• Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the RectumCompletedNCT00086931Phase 1/2
• Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the GallbladderCompletedNCT00084942Phase 2
• Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00084734Phase 1
• Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal CancerCompletedNCT00084721Phase 1
• Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid TumorsCompletedNCT00084708Phase 1
• Irinotecan and Capecitabine in Treating Women With Advanced Breast CancerCompletedNCT00083148Phase 1
• Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal TumorsCompletedNCT00060268Phase 1/2
• High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid TumorsCompletedNCT00060255Phase 2
• Interleukin-2 and Stem Cell Factor in Treating Patients With AIDS or AIDS-Related CancerCompletedNCT00058045Phase 1
• Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before SurgeryCompletedNCT00057798Phase 2
• Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal TractCompletedNCT00055666Not applicable
• Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic DisordersCompletedNCT00055653Phase 2
• Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation TherapyCompletedNCT00054522Phase 2
• BAY 59-8862 in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00054314Phase 2
• Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid TumorsCompletedNCT00054288Phase 1
• Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic LeukemiaCompletedNCT00054171Phase 2
• Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple MyelomaCompletedNCT00054158Phase 2
• Surgery and Photodynamic Therapy in Treating Patients With Malignant MesotheliomaCompletedNCT00054002Phase 2
• Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic AnemiaCompletedNCT00053157Not applicable
• Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous LeukemiaCompletedNCT00053144Phase 1
• Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaCompletedNCT00053131Phase 2
• Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System CancerCompletedNCT00053118Phase 1
• Oxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal CancerCompletedNCT00040820Not applicable
• S-3304 in Treating Patients With Advanced Solid TumorsCompletedNCT00033566Phase 1
• Thalidomide in Treating Anemia in Patients With Myelodysplastic SyndromeCompletedNCT00030550Phase 2
• Photodynamic Therapy With HPPH in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00025571Phase 1
• Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid TumorsCompletedNCT00024141Phase 1
• Vaccine Therapy in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00023985Phase 1
• Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic LeukemiaCompletedNCT00022035Not applicable
• Photodynamic Therapy in Treating Patients With Basal Cell Skin CancerCompletedNCT00017485Phase 1
• Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung CancerCompletedNCT00014066Phase 1
• Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic AnemiaCompletedNCT00004474Phase 3
• Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT00004248Phase 2
• BCG Plus Interferon Alfa 2b in Treating Patients With Bladder CancerCompletedNCT00004122Phase 2
• Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II MesotheliomaCompletedNCT00003974Phase 1

← Roswell Park Cancer Institute overview and focus areas